CLINICAL_TRIALS
trial_result
· 2022-08-08
Clinical Trial Update: Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation [Phase 4]
Summary
Phase 4 trial update comparing observation to progesterone treatment for uterine arteriovenous malformation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HaEmek Medical Center, Israel | Conditions: Arteriovenous Malformations | Phase 4 | Status: UNKNOWN